Tags

Type your tag names separated by a space and hit enter

Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting.
Turk Kardiyol Dern Ars 2012; 40(3):205-12TK

Abstract

OBJECTIVES

We analyzed pentraxin 3 (PTX3) levels and the relation of PTX3 levels with GRACE risk scores in 39 patients with non-ST elevation acute coronary syndrome (ACS) and stabile angina after stenting.

STUDY DESIGN

Seventeen patients with ACS and 22 patients with stabile angina who underwent coronary stenting were included in the study. PTX3 levels were measured serially at admission, at the 8th hour and at the 24th hour after stenting.

RESULTS

While diabetes and hypertension were more frequent in the stabile angina group, leukocyte counts were significantly higher in the ACS group. PTX3 levels measured at the 8th hour were significantly higher in the ACS group compared to the stabile angina group (p=0.003). Strong correlations were observed between 24th hour PTX3 levels and GRACE scores calculated for risk of death and death/MI at admission (in-hospital/to 6 months), and for risk of death/MI at discharge to 6 months (R=0.571, p=0.01, R=0.564, p=0.01; R=0.558, p=0.02, R=0.512, p=0.03; R=0.653, p=0.004, respectively).

CONCLUSION

The serum PTX3 levels may provide important information for the early risk stratification of patients with ACS who underwent coronary stenting.

Authors+Show Affiliations

Department Of Cardiology, Çanakkale Onsekiz Mart University, Medical Faculty, Çanakkale, Turkey. serkankard@gmail.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

22864315

Citation

Saygı, Serkan, et al. "Long Pentraxin-3 Measured at Late Phase Associated With GRACE Risk Scores in Patients With non-ST Elevation Acute Coronary Syndrome and Coronary Stenting." Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir, vol. 40, no. 3, 2012, pp. 205-12.
Saygı S, Kırılmaz B, Tengiz İ, et al. Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting. Turk Kardiyol Dern Ars. 2012;40(3):205-12.
Saygı, S., Kırılmaz, B., Tengiz, İ., Türk, U. Ö., Yıldız, H., Tuzun, N., ... Ercan, E. (2012). Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting. Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir, 40(3), pp. 205-12. doi:10.5543/tkda.2012.90083.
Saygı S, et al. Long Pentraxin-3 Measured at Late Phase Associated With GRACE Risk Scores in Patients With non-ST Elevation Acute Coronary Syndrome and Coronary Stenting. Turk Kardiyol Dern Ars. 2012;40(3):205-12. PubMed PMID: 22864315.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting. AU - Saygı,Serkan, AU - Kırılmaz,Bahadır, AU - Tengiz,İstemihan, AU - Türk,Uğur Önsel, AU - Yıldız,Hicran, AU - Tuzun,Nurullah, AU - Alioğlu,Emin, AU - Tamer,Gülden Sönmez, AU - Ercan,Ertuğrul, PY - 2012/8/7/entrez PY - 2012/8/7/pubmed PY - 2014/1/10/medline SP - 205 EP - 12 JF - Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir JO - Turk Kardiyol Dern Ars VL - 40 IS - 3 N2 - OBJECTIVES: We analyzed pentraxin 3 (PTX3) levels and the relation of PTX3 levels with GRACE risk scores in 39 patients with non-ST elevation acute coronary syndrome (ACS) and stabile angina after stenting. STUDY DESIGN: Seventeen patients with ACS and 22 patients with stabile angina who underwent coronary stenting were included in the study. PTX3 levels were measured serially at admission, at the 8th hour and at the 24th hour after stenting. RESULTS: While diabetes and hypertension were more frequent in the stabile angina group, leukocyte counts were significantly higher in the ACS group. PTX3 levels measured at the 8th hour were significantly higher in the ACS group compared to the stabile angina group (p=0.003). Strong correlations were observed between 24th hour PTX3 levels and GRACE scores calculated for risk of death and death/MI at admission (in-hospital/to 6 months), and for risk of death/MI at discharge to 6 months (R=0.571, p=0.01, R=0.564, p=0.01; R=0.558, p=0.02, R=0.512, p=0.03; R=0.653, p=0.004, respectively). CONCLUSION: The serum PTX3 levels may provide important information for the early risk stratification of patients with ACS who underwent coronary stenting. SN - 1016-5169 UR - https://www.unboundmedicine.com/medline/citation/22864315/Long_pentraxin_3_measured_at_late_phase_associated_with_GRACE_risk_scores_in_patients_with_non_ST_elevation_acute_coronary_syndrome_and_coronary_stenting_ L2 - https://www.journalagent.com/pubmed/linkout.asp?ISSN=1016-5169&PMID=22864315 DB - PRIME DP - Unbound Medicine ER -